Hovione plots global expansion project, looking to boost capacity on both sides of the Atlantic

Hov­ione is go­ing glob­al with its man­u­fac­tur­ing ex­pan­sion, from New Jer­sey all the way to Por­tu­gal.

The CD­MO an­nounced last week it would put $170 mil­lion in­to ex­pan­sions in Por­tu­gal, Ire­land and NJ, in an ef­fort to in­crease its glob­al ca­pac­i­ty by 25%. The move fol­lows an on­go­ing ef­fort since 2016 to ex­pand.

In a press re­lease, COO Jean-Luc Her­beaux said:

These in­vest­ments re­in­force our in­te­grat­ed spe­cial­ized of­fer glob­al­ly, pro­vid­ing our clients with a line of sight for their projects. Fo­cus is placed on fa­cil­i­tat­ing and speed­ing up the drug de­vel­op­ment cy­cle and launch, by pro­vid­ing API man­u­fac­tur­ing, Par­ti­cle En­gi­neer­ing and Tablet­ing ser­vices in each site. Our strat­e­gy con­tin­ues to be to grow or­gan­i­cal­ly via in­vest­ments in our ex­ist­ing sites, which are de­signed for pur­pose. This re­duces the com­plex­i­ty as­so­ci­at­ed with the growth jour­ney and al­lows us to fo­cus our man­age­ment at­ten­tion on what counts most, i.e. guar­an­tee­ing that our clients go to mar­ket with qual­i­ty, safe and ef­fec­tive med­i­cines for their pa­tients.

In New Jer­sey, Hov­ione will add a 31,215-square-foot build­ing next to an al­ready-ex­ist­ing fa­cil­i­ty in East Wind­sor. The move will bring com­mer­cial spray-dry­ing ca­pac­i­ty on­line by 2023, and fur­ther in­vest­ments will help the com­pa­ny fac­tor US-based man­u­fac­tur­ing up through com­mer­cial stage.

In Ire­land, an al­ready-ex­ist­ing site in Cork will be up­grad­ed to add high­ly-po­tent API pro­duc­tion. That ex­pan­sion is set to add an­oth­er 100 jobs over the next three years as Hov­ione plans to add on to the al­ready-ex­ist­ing work­force of around 200. The site has been in op­er­a­tion since 2009.

And in Por­tu­gal, Hov­ione will in­crease its chem­i­cal syn­the­sis ca­pac­i­ty for HPA­PIs. The build­ing will get a new com­mer­cial spray dry­er, which takes a liq­uid stream and sep­a­rates the solute as a sol­id and the sol­vent in­to a va­por. This en­ables the process to be ful­ly au­to­mat­ed and con­tin­u­ous.

‘Hov­ione is in it for life and what bet­ter way to man­i­fest this than through ex­pan­sion of our glob­al ca­pac­i­ty and ca­pa­bil­i­ties. Our sus­tain­able or­gan­ic growth strat­e­gy will al­low us to keep true to those val­ues that have been guid­ing us for more than 60 years,’ CEO Guy Vil­lax said in a press re­lease.

The CD­MO has 60 years of ex­pe­ri­ence un­der its belt. There are four ex­ist­ing man­u­fac­tur­ing sites in the US, Chi­na, Ire­land and Por­tu­gal, and R&D labs in Lis­bon, Por­tu­gal and New Jer­sey.
https://endpts.com/hovione-plots-global-expansion-project-looking-to-boost-capacity-on-both-sides-of-the-atlantic